Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other biologically active molecules. Its structure allows for selective modification in drug design, enhancing metabolic stability and binding affinity. Commonly employed in medicinal chemistry for constructing complex heterocyclic systems, especially in research targeting central nervous system disorders and oncology. The Boc-protected piperidine group facilitates stepwise synthesis, enabling clean coupling reactions in peptide-like frameworks. Its difluoroacetic acid moiety contributes to improved pharmacokinetic properties, such as membrane permeability and resistance to enzymatic degradation.